Bold, science-driven development of novel medicines
We have a bold approach to develop novel medicines for female patients with unmet diseases — specifically non-hormonal treatments that prioritize safety, efficacy, and convenience.
Identify
Strategically identify pathogenesis and pathways known to drive abnormal behavior in diseases that affect the female reproductive system, fertility, pregnancy, and contraception.
Acquire & Optimize
Acquire and optimize compounds with best-in-class potential — rigorously selected for their ability to address unmet needs with superior efficacy and safety profiles.
Develop
Develop medicines that have the potential to improve female patient outcomes without compromising convenience and comfortability — therapies women will actually use.
This vision is enabled by:
Internal expertise
An exceptional internal team with a deep understanding of women’s health diseases and significant experience pioneering innovative treatments for these complex conditions.
Global clinical network
A vast external global network of community and academic clinical trial sites dedicated to research in women’s health diseases, ensuring broad reach and diverse patient populations.